APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cold, Cough and Sore Throat Remedies

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cold, Cough and Sore Throat Remedies Market Analysis and Forecast 2026-2032

Report ID 173979410219 December 2025195 pages

Choose your research edition.

Industry ResearchCold, Cough and Sore Throat Remedies Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Cold, Cough and Sore Throat Remedies Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Cold, Cough and Sore Throat Remedies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cold, Cough and Sore Throat Remedies Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cold, Cough and Sore Throat Remedies Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cold, Cough and Sore Throat Remedies market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cold, Cough and Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cold, Cough and Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cold, Cough and Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cold, Cough and Sore Throat Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cold, Cough and Sore Throat Remedies include Prestige Brands, Reckitt Benckiser, Sun Pharmaceutical Industries, AstraZeneca, Bayer, GlaxoSmithKline, Pfizer, Novartis and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cold, Cough and Sore Throat Remedies, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cold, Cough and Sore Throat Remedies, also provides the revenue of main regions and countries. Of the upcoming market potential for Cold, Cough and Sore Throat Remedies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cold, Cough and Sore Throat Remedies revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cold, Cough and Sore Throat Remedies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cold, Cough and Sore Throat Remedies revenue, projected growth trends, production technology, application and end-user industry.

Cold, Cough and Sore Throat Remedies Segment by Company

Prestige Brands

Reckitt Benckiser

Sun Pharmaceutical Industries

AstraZeneca

Bayer

GlaxoSmithKline

Pfizer

Novartis

Johnson & Johnson

Cold, Cough and Sore Throat Remedies Segment by Type

Decongestants

Antibiotics

Antihistamines

Expectorants

Bronchodilators

Others

Cold, Cough and Sore Throat Remedies Segment by Application

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Cold, Cough and Sore Throat Remedies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold, Cough and Sore Throat Remedies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cold, Cough and Sore Throat Remedies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold, Cough and Sore Throat Remedies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cold, Cough and Sore Throat Remedies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cold, Cough and Sore Throat Remedies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cold, Cough and Sore Throat Remedies revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cold, Cough and Sore Throat Remedies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Decongestants Major Player Table 3. Antibiotics Major Player Table 4. Antihistamines Major Player Table 5. Expectorants Major Player Table 6. Bronchodilators Major Player Table 7. Others Major Player Table 8. Global Cold, Cough and Sore Throat Remedies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Pharmacies Major Player Table 10. Retail Pharmacies Major Player Table 11. Drug Stores Major Player Table 12. Cold, Cough and Sore Throat Remedies Industry Trends Table 13. Cold, Cough and Sore Throat Remedies Industry Drivers Table 14. Cold, Cough and Sore Throat Remedies Industry Opportunities and Challenges Table 15. Cold, Cough and Sore Throat Remedies Industry Restraints Table 16. Global Cold, Cough and Sore Throat Remedies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Cold, Cough and Sore Throat Remedies Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Cold, Cough and Sore Throat Remedies Market Share by Region (2021-2026) Table 19. Global Cold, Cough and Sore Throat Remedies Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Cold, Cough and Sore Throat Remedies Market Share by Region (2027-2032) Table 21. Global Cold, Cough and Sore Throat Remedies Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Players (2021-2026) Table 23. Global Cold, Cough and Sore Throat Remedies Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Cold, Cough and Sore Throat Remedies Key Players Headquarters & Area Served Table 25. Global Cold, Cough and Sore Throat Remedies Players, Product Type & Application Table 26. Global Cold, Cough and Sore Throat Remedies Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Cold, Cough and Sore Throat Remedies by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Cold, Cough and Sore Throat Remedies Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Type (2021-2026) Table 33. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Type (2027-2032) Table 34. Global Cold, Cough and Sore Throat Remedies Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Application (2021-2026) Table 38. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Application (2027-2032) Table 39. Prestige Brands Company Information Table 40. Prestige Brands Business Overview Table 41. Prestige Brands Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Prestige Brands Cold, Cough and Sore Throat Remedies Product Portfolio Table 43. Prestige Brands Recent Development Table 44. Reckitt Benckiser Company Information Table 45. Reckitt Benckiser Business Overview Table 46. Reckitt Benckiser Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Reckitt Benckiser Cold, Cough and Sore Throat Remedies Product Portfolio Table 48. Reckitt Benckiser Recent Development Table 49. Sun Pharmaceutical Industries Company Information Table 50. Sun Pharmaceutical Industries Business Overview Table 51. Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Product Portfolio Table 53. Sun Pharmaceutical Industries Recent Development Table 54. AstraZeneca Company Information Table 55. AstraZeneca Business Overview Table 56. AstraZeneca Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. AstraZeneca Cold, Cough and Sore Throat Remedies Product Portfolio Table 58. AstraZeneca Recent Development Table 59. Bayer Company Information Table 60. Bayer Business Overview Table 61. Bayer Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Bayer Cold, Cough and Sore Throat Remedies Product Portfolio Table 63. Bayer Recent Development Table 64. GlaxoSmithKline Company Information Table 65. GlaxoSmithKline Business Overview Table 66. GlaxoSmithKline Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. GlaxoSmithKline Cold, Cough and Sore Throat Remedies Product Portfolio Table 68. GlaxoSmithKline Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Pfizer Cold, Cough and Sore Throat Remedies Product Portfolio Table 73. Pfizer Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Novartis Cold, Cough and Sore Throat Remedies Product Portfolio Table 78. Novartis Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Johnson & Johnson Cold, Cough and Sore Throat Remedies Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. North America Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Cold, Cough and Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Cold, Cough and Sore Throat Remedies Revenue by Country (2021-2026) & (US$ Million) Table 90. North America Cold, Cough and Sore Throat Remedies Revenue by Country (US$ Million) & (2027-2032) Table 91. Europe Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Cold, Cough and Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Cold, Cough and Sore Throat Remedies Revenue by Country (2021-2026) & (US$ Million) Table 97. Europe Cold, Cough and Sore Throat Remedies Revenue by Country (US$ Million) & (2027-2032) Table 98. China Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026) & (US$ Million) Table 99. China Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032) & (US$ Million) Table 100. China Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026) & (US$ Million) Table 101. China Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026) & (US$ Million) Table 103. Asia Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032) & (US$ Million) Table 104. Asia Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026) & (US$ Million) Table 105. Asia Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Cold, Cough and Sore Throat Remedies Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Cold, Cough and Sore Throat Remedies Revenue by Region (US$ Million) & (2021-2026) Table 108. Asia Cold, Cough and Sore Throat Remedies Revenue by Region (US$ Million) & (2027-2032) Table 109. SAMEA Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026) & (US$ Million) Table 110. SAMEA Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032) & (US$ Million) Table 111. SAMEA Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026) & (US$ Million) Table 112. SAMEA Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032) & (US$ Million) Table 113. SAMEA Cold, Cough and Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. SAMEA Cold, Cough and Sore Throat Remedies Revenue by Country (2021-2026) & (US$ Million) Table 115. SAMEA Cold, Cough and Sore Throat Remedies Revenue by Country (US$ Million) & (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Cold, Cough and Sore Throat Remedies Image Figure 2. Global Cold, Cough and Sore Throat Remedies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cold, Cough and Sore Throat Remedies Market Size Share 2021 VS 2025 VS 2032 Figure 4. Decongestants Image Figure 5. Antibiotics Image Figure 6. Antihistamines Image Figure 7. Expectorants Image Figure 8. Bronchodilators Image Figure 9. Others Image Figure 10. Global Cold, Cough and Sore Throat Remedies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Cold, Cough and Sore Throat Remedies Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Pharmacies Image Figure 13. Retail Pharmacies Image Figure 14. Drug Stores Image Figure 15. Global Cold, Cough and Sore Throat Remedies Market Size (US$ Million) & (2021-2032) Figure 16. Global Cold, Cough and Sore Throat Remedies Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Cold, Cough and Sore Throat Remedies Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Cold, Cough and Sore Throat Remedies Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Cold, Cough and Sore Throat Remedies Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cold, Cough and Sore Throat Remedies Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Type (2021-2032) Figure 23. Global Cold, Cough and Sore Throat Remedies Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Application (2021-2032) Figure 26. North America Cold, Cough and Sore Throat Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032) Figure 28. North America Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032) Figure 29. North America Cold, Cough and Sore Throat Remedies Revenue Share by Country (2021-2032) Figure 30. United States Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Cold, Cough and Sore Throat Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032) Figure 35. Europe Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032) Figure 36. Europe Cold, Cough and Sore Throat Remedies Revenue Share by Country (2021-2032) Figure 37. Germany Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Cold, Cough and Sore Throat Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032) Figure 47. China Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032) Figure 48. Asia Cold, Cough and Sore Throat Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032) Figure 50. Asia Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032) Figure 51. Asia Cold, Cough and Sore Throat Remedies Revenue Share by Region (2021-2032) Figure 52. Japan Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Cold, Cough and Sore Throat Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032) Figure 60. SAMEA Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032) Figure 61. SAMEA Cold, Cough and Sore Throat Remedies Revenue Share by Country (2021-2032) Figure 62. Brazil Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Cold, Cough and Sore Throat Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Decongestants
  • Antibiotics
  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Others
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
Companies covered
  • Prestige Brands
  • Reckitt Benckiser
  • Sun Pharmaceutical Industries
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cold, Cough and Sore Throat Remedies Market by Type
  3. 1.2.1 Global Cold, Cough and Sore Throat Remedies Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Decongestants
  5. 1.2.3 Antibiotics
  6. 1.2.4 Antihistamines
  7. 1.2.5 Expectorants
  8. 1.2.6 Bronchodilators
  9. 1.2.7 Others
  10. 1.3 Cold, Cough and Sore Throat Remedies Market by Application
  11. 1.3.1 Global Cold, Cough and Sore Throat Remedies Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital Pharmacies
  13. 1.3.3 Retail Pharmacies
  14. 1.3.4 Drug Stores
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Cold, Cough and Sore Throat Remedies Market Dynamics
  1. 2.1 Cold, Cough and Sore Throat Remedies Industry Trends
  2. 2.2 Cold, Cough and Sore Throat Remedies Industry Drivers
  3. 2.3 Cold, Cough and Sore Throat Remedies Industry Opportunities and Challenges
  4. 2.4 Cold, Cough and Sore Throat Remedies Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cold, Cough and Sore Throat Remedies Market Perspective (2021-2032)
  2. 3.2 Global Cold, Cough and Sore Throat Remedies Growth Trends by Region
  3. 3.2.1 Global Cold, Cough and Sore Throat Remedies Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cold, Cough and Sore Throat Remedies Market Size by Region (2021-2026)
  5. 3.2.3 Global Cold, Cough and Sore Throat Remedies Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cold, Cough and Sore Throat Remedies Revenue by Players
  2. 4.1.1 Global Cold, Cough and Sore Throat Remedies Revenue by Players (2021-2026)
  3. 4.1.2 Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cold, Cough and Sore Throat Remedies Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cold, Cough and Sore Throat Remedies Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cold, Cough and Sore Throat Remedies Key Players Headquarters & Area Served
  7. 4.4 Global Cold, Cough and Sore Throat Remedies Players, Product Type & Application
  8. 4.5 Global Cold, Cough and Sore Throat Remedies Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cold, Cough and Sore Throat Remedies Market CR5 and HHI
  11. 4.6.3 2025 Cold, Cough and Sore Throat Remedies Tier 1, Tier 2, and Tier 3
5 Cold, Cough and Sore Throat Remedies Market Size by Type
  1. 5.1 Global Cold, Cough and Sore Throat Remedies Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2032)
  3. 5.3 Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Type (2021-2032)
6 Cold, Cough and Sore Throat Remedies Market Size by Application
  1. 6.1 Global Cold, Cough and Sore Throat Remedies Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2032)
  3. 6.3 Global Cold, Cough and Sore Throat Remedies Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Prestige Brands
  2. 7.1.1 Prestige Brands Company Information
  3. 7.1.2 Prestige Brands Business Overview
  4. 7.1.3 Prestige Brands Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Prestige Brands Cold, Cough and Sore Throat Remedies Product Portfolio
  6. 7.1.5 Prestige Brands Recent Developments
  7. 7.2 Reckitt Benckiser
  8. 7.2.1 Reckitt Benckiser Company Information
  9. 7.2.2 Reckitt Benckiser Business Overview
  10. 7.2.3 Reckitt Benckiser Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Reckitt Benckiser Cold, Cough and Sore Throat Remedies Product Portfolio
  12. 7.2.5 Reckitt Benckiser Recent Developments
  13. 7.3 Sun Pharmaceutical Industries
  14. 7.3.1 Sun Pharmaceutical Industries Company Information
  15. 7.3.2 Sun Pharmaceutical Industries Business Overview
  16. 7.3.3 Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Product Portfolio
  18. 7.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Cold, Cough and Sore Throat Remedies Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 Bayer
  26. 7.5.1 Bayer Company Information
  27. 7.5.2 Bayer Business Overview
  28. 7.5.3 Bayer Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bayer Cold, Cough and Sore Throat Remedies Product Portfolio
  30. 7.5.5 Bayer Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Cold, Cough and Sore Throat Remedies Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Cold, Cough and Sore Throat Remedies Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Cold, Cough and Sore Throat Remedies Product Portfolio
  48. 7.8.5 Novartis Recent Developments
  49. 7.9 Johnson & Johnson
  50. 7.9.1 Johnson & Johnson Company Information
  51. 7.9.2 Johnson & Johnson Business Overview
  52. 7.9.3 Johnson & Johnson Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Johnson & Johnson Cold, Cough and Sore Throat Remedies Product Portfolio
  54. 7.9.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America Cold, Cough and Sore Throat Remedies Revenue (2021-2032)
  2. 8.2 North America Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2032)
  3. 8.2.1 North America Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026)
  4. 8.2.2 North America Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032)
  5. 8.3 North America Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032)
  6. 8.4 North America Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2032)
  7. 8.4.1 North America Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026)
  8. 8.4.2 North America Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032)
  9. 8.5 North America Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032)
  10. 8.6 North America Cold, Cough and Sore Throat Remedies Revenue by Country
  11. 8.6.1 North America Cold, Cough and Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cold, Cough and Sore Throat Remedies Revenue by Country (2021-2026)
  13. 8.6.3 North America Cold, Cough and Sore Throat Remedies Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Cold, Cough and Sore Throat Remedies Revenue (2021-2032)
  2. 9.2 Europe Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032)
  5. 9.3 Europe Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032)
  9. 9.5 Europe Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cold, Cough and Sore Throat Remedies Revenue by Country
  11. 9.6.1 Europe Cold, Cough and Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cold, Cough and Sore Throat Remedies Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cold, Cough and Sore Throat Remedies Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Cold, Cough and Sore Throat Remedies Revenue (2021-2032)
  2. 10.2 China Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2032)
  3. 10.2.1 China Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026)
  4. 10.2.2 China Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032)
  5. 10.3 China Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032)
  6. 10.4 China Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2032)
  7. 10.4.1 China Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026)
  8. 10.4.2 China Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032)
  9. 10.5 China Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cold, Cough and Sore Throat Remedies Revenue (2021-2032)
  2. 11.2 Asia Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032)
  5. 11.3 Asia Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032)
  9. 11.5 Asia Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cold, Cough and Sore Throat Remedies Revenue by Country
  11. 11.6.1 Asia Cold, Cough and Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cold, Cough and Sore Throat Remedies Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cold, Cough and Sore Throat Remedies Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cold, Cough and Sore Throat Remedies Revenue (2021-2032)
  2. 12.2 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cold, Cough and Sore Throat Remedies Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cold, Cough and Sore Throat Remedies Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Country
  11. 12.6.1 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cold, Cough and Sore Throat Remedies Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst